‘Not checking out yet’: Woman With Incurable Cancer Vows to Keep Fighting
Heather Appleton just renewed her passport for another ten years.
“I’m not checking out yet,” said Appleton, 61, who has the incurable cancer, Multiple Myeloma.
Appleton was diagnosed eight years ago after getting injured while playing in a slo-pitch game in Dorchester.
“I felt this pop in my back and I had actually fractured my spine because there was a tumor,” said Appleton, who didn’t even find out until months later.
“I thought it was just muscle pain. I travelled to Ireland to my daughter’s wedding, and I didn’t find out the severity until I went to physiotherapy, acupuncture and my family doctor. I could hardly walk with the pain, it was so bad.”
She went into urgent care, had imaging done and found the tumor. It was emergency surgery then chemotherapy.
“It’s incurable, but it’s treatable,” she said.
“It has been a roller coaster. I can’t lie.”
Ev McDowell, going on 24 years since her initial diagnosis, started the London Myeloma Support Group.
“I remember meeting Heather just shortly after her diagnosis, and I think she had it pretty rough with a lot of back pain before they got a diagnosis,” said McDowell.
“She’s a real fighter. I remember her having a stem cell transplant and it not working, and I felt so bad for her. There is a drug she’s been on for a long time now, and I just find she’s a really resilient woman who is active and just lives the best life she can.”
Appleton is back to hosting a low impact cardio Zoom class two or three times a week and led the warmup prior to Sunday’s Walk of Champions in Dorchester for survivors of multiple myeloma, their families and caregivers.
This year’s walk has raised close to $100,000 and in the since years since its inception, more than $1 million has been raised for research.
In 2020, it was estimated that 3,400 Canadians would be diagnosed with Multiple Myeloma, an incurable cancer of the plasma cells in the bone marrow.
However, in the last few years research has produced new treatments, increasing the lifespan (which was recently two to five years) of patients and the hope is that a cure will soon be in sight.
“It’s kind of daunting, but the life expectancy is increasing,” said Appleton.
“We’re an expensive bunch of cancer patients because the drugs are expensive, but they’re working. The healthcare that I’ve had in London has been excellent.”
She plans on attending this Walk of Champions for years to come and take advantage of that 10-year passport.
Treating Tumors With CyberKnife Radiation Therapy: CyberKnife is a noninvasive radiosurgery system that treats some cancerous and noncancerous tumors and certain other conditions – without the need for incisions. Radiosurgery is precisely focused radiation therapy that targets cancer cells and other types of diseased tissue, minimizing exposure to nearby, healthy tissue.
CyberKnife offers a number of advantages over other radiosurgery systems and conventional radiation therapy: CyberKnife delivers treatment precision within a millimeter (the thickness of a credit card). Important advances in imaging, robotics, and other technologies help drive the CyberKnife system’s unprecedented accuracy and results. This ability to precisely target the delivery of radiation provides a number of important benefits:
- More radiation to the target: CyberKnife enables higher-dose radiation to the target region for faster, more effective treatment than with standard radiation therapy.
- Less radiation to healthy tissue: Surrounding healthy tissues receive significantly less radiation than with traditional radiation therapy.
- Safe alternative to radiation: CyberKnife can safely treat tumors that had previously received radiotherapy. It’s also safe and effective for other conditions and tumors that cannot be treated with traditional radiation because they are too close to critical brain, spinal cord, or other tissue.
- Advanced imaging for treatment planning: Each tumor has a unique shape, size, and location. CyberKnife’s technology integrates and studies results from various forms of imaging, such as CT, MRI, and PET scans, to develop a treatment plan for targeting and delivering the radiation beam.
- Real-time tumor tracking: The system uses specialized imaging and tumor tracking capabilities to verify the exact tumor position before delivering the radiation beam. The tracking continues during the delivery of radiation, accounting for any movements you make, including breathing. This tracking ensures that radiation is delivered precisely to the tumor and not to surrounding healthy tissue. It also protects healthy tissue by blocking the delivery of radiation should the tumor moves out of its beam.
- The Next Step: At CyberKnife Miami we take a multispecialty approach to treating cancerous and noncancerous tumors, neurologic conditions, and other conditions using CyberKnife radiation therapy. We can treat people quickly – minimizing impact on daily life. Call us today to set up a consultation, or to get a second opinion. The more you know, the greater chance of getting treated successfully. You can reach our team at 305-279-2900.